Business Standard

Zydus receives USFDA approval for Bisoprolol Fumarate Tablets

Image

Capital Market

Used to treat high blood pressure

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to market Bisoprolol Fumarate Tablets USP 5 mg and 10 mg. USRLD: Zebeta.

Bisoprolol Fumarate Tablets are used to treat high blood pressure. They can be used alone or in combination with other high blood pressure medications to lower blood pressure. The drug will be manufactured at the group's formulation manufacturing facility at, SEZ, Ahmedabad, India and will be distributed by Viona Pharmaceuticals Inc.

Bisoprolol Fumarate Tablets had annual sales of USD 30 million in the United States according to IQVIA data.

 

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jul 26 2022 | 6:16 PM IST

Explore News